Welcome to vnonline.co.uk

vnonline.co.uk provides the veterinary nursing profession with the latest news and industry developments, as well as events, resources, learning materials and careers.

Our website is dedicated to veterinary nurses and we strive to provide a platform where you can voice and explore your interests.

Not a member yet? Sign up for free!

Register for free with vnonline.co.uk to gain unlimited access to news, resources, jobs and much more!



Click here to become a member






Log in to vnonline

Forgot your password?

Posted: 2nd September 2020

Vetoquinol completes acquisition of Profender® and Drontal®
Vetoquinol has completed its acquisition of the Profender and Drontal product families.
“These two strong brands fit perfectly at the core of Vetoquinol strategy” - Matthieu Frechin.

Vetoquinol has completed its acquisition of Profender® and Drontal® product families, previously owned by Bayer Animal Health.

The acquisition is related to Elanco’s acquisition of Bayer AG’s animal health business, finalised on 1 August 2020. The Profender and Drontal families of products are spot-on and tablet de-wormer products for cats and dogs.

Vetoquinol CEO Matthieu Frechin said: "We are extremely pleased to share the completion of the acquisition of the Profender®and Drontal®product lines. These two strong brands fit perfectly at the core of Vetoquinol strategy.

“From now on, they will significantly increase the size of our business and our visibility in the parasiticide segment, one of our strategic therapeutic areas. Also, effectively immediately, these products and brands strengthen our portfolio of Essentials, the engine of our growth. I am proud of the Vetoquinol teams whom made this deal happen despite the challenging circumstances under the COVID global context.”

Elanco’s acquisition of Bayer Animal Health is valued at $6.89 billion. The transaction elevates Elanco’s pet business to approximately 50 per cent of revenues and almost triples the company’s international pet health business.



Become a member or log in to add this story to your CPD history



Latest news | Careers | Events | Resources | Contact us | Terms and conditions | Data Protection and Privacy |Cookie policy | About us | Copyright
© 2024 Vision Media, all rights reserved. vnonline.co.uk is not responsible for the content of external websites.